| Dr Michelle M Hill, DO | |
|
575b Blues Lake Pkwy, Rolla, MO 65401 | |
| (573) 364-2007 | |
| (573) 202-2455 |
| Full Name | Dr Michelle M Hill |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 575b Blues Lake Pkwy, Rolla, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679894232 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 2018015073 (Missouri) | Primary |
| Entity Name | Phelps County Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891766051 PECOS PAC ID: 2860391158 Enrollment ID: O20040106000405 |
News Archive
Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced the publication of interim results from a phase II study suggesting that the antisense oligonucleotide GS-101 (eye drops) is safe and effective at inhibiting and regressing corneal neovascularisation (abnormal new blood vessel growth).
Today, AdMeTech Foundation in cooperation with Nick Kosovich of Dancing with the Stars, Arthur Murray International (AMI), Philips Healthcare, Mary Murphy of Fox TV Hit So You Think You Can Dance and other key leaders of the dancing community have launched Dance for the Cure of Prostate Cancer as a national awareness and fundraising campaign to end the prostate cancer crisis.
TSO3 Inc. is pleased to announce that it has filed a final short form prospectus with the securities regulatory authorities in all provinces of Canada with respect to a previously announced public offering of 10,000,000 common shares for gross proceeds to the Company of C$16 million. The prospectus also qualifies for the distribution of 150,000 Common shares sold by Simon Robitaille, one of the Company's founders and Chief Scientific Officer, for gross proceeds of $240,000.
Insurers' "worst nightmare" is that the Supreme Court would overturn the health law's insurance requirement but leave the rest of the overhaul intact. Employers are being advised to continue working toward meeting the law's deadlines.
A combination therapy for treating cancer discovered at the University of Colorado Cancer Center showed improved survival rates in patients with advanced non-small cell lung cancer (NSCLC), according to results from a double-blind, placebo-controlled phase 2 trial run by Syndax Pharmaceuticals.
› Verified 2 days ago
| Entity Name | Compass Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285619494 PECOS PAC ID: 1951206754 Enrollment ID: O20040408000955 |
News Archive
Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced the publication of interim results from a phase II study suggesting that the antisense oligonucleotide GS-101 (eye drops) is safe and effective at inhibiting and regressing corneal neovascularisation (abnormal new blood vessel growth).
Today, AdMeTech Foundation in cooperation with Nick Kosovich of Dancing with the Stars, Arthur Murray International (AMI), Philips Healthcare, Mary Murphy of Fox TV Hit So You Think You Can Dance and other key leaders of the dancing community have launched Dance for the Cure of Prostate Cancer as a national awareness and fundraising campaign to end the prostate cancer crisis.
TSO3 Inc. is pleased to announce that it has filed a final short form prospectus with the securities regulatory authorities in all provinces of Canada with respect to a previously announced public offering of 10,000,000 common shares for gross proceeds to the Company of C$16 million. The prospectus also qualifies for the distribution of 150,000 Common shares sold by Simon Robitaille, one of the Company's founders and Chief Scientific Officer, for gross proceeds of $240,000.
Insurers' "worst nightmare" is that the Supreme Court would overturn the health law's insurance requirement but leave the rest of the overhaul intact. Employers are being advised to continue working toward meeting the law's deadlines.
A combination therapy for treating cancer discovered at the University of Colorado Cancer Center showed improved survival rates in patients with advanced non-small cell lung cancer (NSCLC), according to results from a double-blind, placebo-controlled phase 2 trial run by Syndax Pharmaceuticals.
› Verified 2 days ago
| Entity Name | Pcrmc Medical Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124237227 PECOS PAC ID: 1557454063 Enrollment ID: O20070829000437 |
News Archive
Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced the publication of interim results from a phase II study suggesting that the antisense oligonucleotide GS-101 (eye drops) is safe and effective at inhibiting and regressing corneal neovascularisation (abnormal new blood vessel growth).
Today, AdMeTech Foundation in cooperation with Nick Kosovich of Dancing with the Stars, Arthur Murray International (AMI), Philips Healthcare, Mary Murphy of Fox TV Hit So You Think You Can Dance and other key leaders of the dancing community have launched Dance for the Cure of Prostate Cancer as a national awareness and fundraising campaign to end the prostate cancer crisis.
TSO3 Inc. is pleased to announce that it has filed a final short form prospectus with the securities regulatory authorities in all provinces of Canada with respect to a previously announced public offering of 10,000,000 common shares for gross proceeds to the Company of C$16 million. The prospectus also qualifies for the distribution of 150,000 Common shares sold by Simon Robitaille, one of the Company's founders and Chief Scientific Officer, for gross proceeds of $240,000.
Insurers' "worst nightmare" is that the Supreme Court would overturn the health law's insurance requirement but leave the rest of the overhaul intact. Employers are being advised to continue working toward meeting the law's deadlines.
A combination therapy for treating cancer discovered at the University of Colorado Cancer Center showed improved survival rates in patients with advanced non-small cell lung cancer (NSCLC), according to results from a double-blind, placebo-controlled phase 2 trial run by Syndax Pharmaceuticals.
› Verified 2 days ago
| Entity Name | Psychological & Behavioral Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811915713 PECOS PAC ID: 0446243760 Enrollment ID: O20181204002777 |
News Archive
Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced the publication of interim results from a phase II study suggesting that the antisense oligonucleotide GS-101 (eye drops) is safe and effective at inhibiting and regressing corneal neovascularisation (abnormal new blood vessel growth).
Today, AdMeTech Foundation in cooperation with Nick Kosovich of Dancing with the Stars, Arthur Murray International (AMI), Philips Healthcare, Mary Murphy of Fox TV Hit So You Think You Can Dance and other key leaders of the dancing community have launched Dance for the Cure of Prostate Cancer as a national awareness and fundraising campaign to end the prostate cancer crisis.
TSO3 Inc. is pleased to announce that it has filed a final short form prospectus with the securities regulatory authorities in all provinces of Canada with respect to a previously announced public offering of 10,000,000 common shares for gross proceeds to the Company of C$16 million. The prospectus also qualifies for the distribution of 150,000 Common shares sold by Simon Robitaille, one of the Company's founders and Chief Scientific Officer, for gross proceeds of $240,000.
Insurers' "worst nightmare" is that the Supreme Court would overturn the health law's insurance requirement but leave the rest of the overhaul intact. Employers are being advised to continue working toward meeting the law's deadlines.
A combination therapy for treating cancer discovered at the University of Colorado Cancer Center showed improved survival rates in patients with advanced non-small cell lung cancer (NSCLC), according to results from a double-blind, placebo-controlled phase 2 trial run by Syndax Pharmaceuticals.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michelle M Hill, DO 1050 W 10th St, Rolla, MO 65401-2905 Ph: (573) 364-9000 | Dr Michelle M Hill, DO 575b Blues Lake Pkwy, Rolla, MO 65401 Ph: (573) 364-2007 |
News Archive
Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced the publication of interim results from a phase II study suggesting that the antisense oligonucleotide GS-101 (eye drops) is safe and effective at inhibiting and regressing corneal neovascularisation (abnormal new blood vessel growth).
Today, AdMeTech Foundation in cooperation with Nick Kosovich of Dancing with the Stars, Arthur Murray International (AMI), Philips Healthcare, Mary Murphy of Fox TV Hit So You Think You Can Dance and other key leaders of the dancing community have launched Dance for the Cure of Prostate Cancer as a national awareness and fundraising campaign to end the prostate cancer crisis.
TSO3 Inc. is pleased to announce that it has filed a final short form prospectus with the securities regulatory authorities in all provinces of Canada with respect to a previously announced public offering of 10,000,000 common shares for gross proceeds to the Company of C$16 million. The prospectus also qualifies for the distribution of 150,000 Common shares sold by Simon Robitaille, one of the Company's founders and Chief Scientific Officer, for gross proceeds of $240,000.
Insurers' "worst nightmare" is that the Supreme Court would overturn the health law's insurance requirement but leave the rest of the overhaul intact. Employers are being advised to continue working toward meeting the law's deadlines.
A combination therapy for treating cancer discovered at the University of Colorado Cancer Center showed improved survival rates in patients with advanced non-small cell lung cancer (NSCLC), according to results from a double-blind, placebo-controlled phase 2 trial run by Syndax Pharmaceuticals.
› Verified 2 days ago
Mignon M Makos, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1050 W 10th St, Rolla, MO 65401 Phone: 573-364-9000 Fax: 816-364-3894 | |
Dr. Sreekant Kodela, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1450 E 10th St, Rolla, MO 65401 Phone: 888-403-1071 | |
Dr. Lirong Zhu, M.D., PH.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1605 Martin Springs Dr, Suite 360b, Rolla, MO 65401 Phone: 573-458-6380 Fax: 573-458-6464 | |
Dr. Shannon Liane Robinson, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1000 W 10th St, Rolla, MO 65401 Phone: 573-364-9000 Fax: 573-202-2484 | |
Dr. Sasan Moshirzadeh, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1050 W 10th St, Rolla, MO 65401 Phone: 573-364-9000 Fax: 573-202-2484 | |
Madeleine A Philpot, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 575 Blues Lake Parkway, Pcrmc Center Clinic, Rolla, MO 65401 Phone: 573-426-2214 Fax: 573-202-2455 |